About Auris Medical
Auris Medical is a company based in Basel (Switzerland) founded in 2003. Auris Medical has raised $60.68 million across 4 funding rounds from investors including Hercules Capital, Idinvest Partners and Sofinnova Partners. Auris Medical offers products and services including AM-401, AM-411, Bentrio Nasal Spray, and Inner Ear Therapeutics. Auris Medical operates in a competitive market with competitors including Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Spiral Therapeutics, among others.
- Headquarter Basel, Switzerland
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Altamira Therapeutics Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$60.68 M (USD)
in 4 rounds
-
Latest Funding Round
$5.5 M (USD), Post-IPO
Feb 09, 2018
-
Investors
Hercules Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Auris Medical
Auris Medical offers a comprehensive portfolio of products and services, including AM-401, AM-411, Bentrio Nasal Spray, and Inner Ear Therapeutics.
Targets KRAS-driven cancer through RNA delivery technologies
Addresses rheumatoid arthritis via preclinical RNA therapeutics
Focuses on allergy treatments being divested
Develops solutions for inner ear disorders for potential licensing
People of Auris Medical
Unlock access to complete
Leadership Team
6 people
Finance and Accounting
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Auris Medical
Auris Medical has successfully raised a total of $60.68M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5.5 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Auris Medical
Auris Medical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Hercules Capital, Idinvest Partners and Sofinnova Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Locked | Locked | Locked | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
Equity investments are provided to low and middle market companies.
|
Locked | Locked | Locked |
Investor details for Auris Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Auris Medical
Investment portfolio details for Auris Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Auris Medical
Detailed financials for Auris Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Auris Medical Comparisons
Peer comparison for Auris Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Auris Medical
Auris Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Spiral Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| Locked | Locked | Locked |
Developer of therapeutics to treat diabetes and eye diseases
|
|
| Locked | Locked | Locked |
Developer of gene therapies to restore and preserve hearing capabilities in genetically defined populations
|
|
| Locked | Locked | Locked |
Therapeutics for balance disorders and hearing loss are developed.
|
Detailed competitors of Auris Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Auris Medical
Complete news archive for Auris Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auris Medical
Auris Medical was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Auris Medical is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Auris Medical is a funded company, having raised a total of $60.68M across 4 funding rounds to date.
Auris Medical is dedicated to developing novel pharmaceutical therapies for inner ear diseases tinnitus, hearing loss and menieres disease. Pipeline includes 2 late stage candidates AM-101 for tinnitus and AM-111 for sudden deafness. Other preclinical stage candidates include AM-102 for tinnitus and AM-123 for rhinology study. Company has also developed Intratympanic injection to deliver low drug doses to inner ear and minimize systemic side effects.
Auris Medical's top competitors include Decibel Therapeutics, Lyra Therapeutics and Akouos.
Auris Medical offers AM-401, AM-411, Bentrio Nasal Spray, and Inner Ear Therapeutics.
Auris Medical has 3 investors. Key investors include Hercules Capital, Idinvest Partners, and Sofinnova Partners.